Karyopharm Therapeutics is a clinical-stage pharmaceutical company focused on the discovery and development of novel first in-class drugs directed against nuclear transport targets for
the treatment of cancer and other major diseases.
The Executive Director of Pharmaceutical Sciences will lead a dynamic and growing CMC operations team to ensure that appropriate scientific, regulatory, and quality standards are followed across process chemistry, analytical chemistry, formulation development, and clinical supply chain activities. This role will lead all outsourced manufacturing/production, and will manage the team of scientists and experts who develop and execute strategies for the CMC development of Karyopharm programs through the use of CMOs, CROs and CMDOs. The Executive Director will lead CMC alliance activities as part of the global development of all clinical programs. The AVP will provide strong scientific and technical leadership as well as mentorship and managerial expertise to internal Karyopharm teams.
Karyopharm Therapeutics Inc. (the "Company") is an equal opportunity employer. All qualified applicants will be considered without regard to age, race, color, sex, religion/creed, national origin, marital status, ancestry, citizenship, military, reservist or veteran status, pregnancy, sexual orientation or preference, gender identity, gender expression, physical or mental disability, genetic predisposition or carrier status, or any other category protected under applicable federal, state or local law. Consistent with its obligations under applicable law, the Company will make reasonable accommodations for qualified individuals with disabilities. If you require an accommodation in the application process, please contact a member of the Company’s Human Resources department.